Conference Day One |
Wednesday, September 24, 2025

8:00 am Morning Coffee & Registration

8:50 am Chairs Opening Remarks

Optimizing Raw Materials to Improve mRNA Yield, Quality & Reduce Cost for Future-Proofing Regulatory Success at Scale

9:00 am Bridging the Innovation Gap: Characterizing New Materials & Translating mRNA Platform Advances into GMP-Ready Processes

9:30 am CMC, from pDNA and mRNA to LNP with Multiple Nucleic Acids Payloads

10:00 am Fireside Chat: Enhancing Plasmid DNA Quality Through GMP Compliance, Assay Design & Poly-A Control to Improve IVT Performance

10:30 am Morning Break & Speed Networking

Synopsis

Our dedicated speed networking session is the perfect opportunity to have in-depth conversations and forge long-lasting connections with fellow technical experts working within mRNA process development & CMC.

Track 1: Research Scale

Optimizing Process Development for Emerging mRNA Modalities to Expand Indication Reach & Maximize Therapeutic Performance

11:30 am Novel mRNA Drug Product to Improve Potency

Shirisha Meda, Associate Director, BioNTech

12:00 pm Session Reserved For Syngoi

12:30 pm Tackling Stability Challenges in Self-Amplifying mRNA to Strengthen Early-Stage Development & Set the Foundation for Scale

Eric Yearley, Associate Director, CSL
Track 2: IND Enabling & Clinical Scale

1:00 pm Lunch Break

Track 1: Research Scale

Strengthening Manufacturing to Overcome Gene Editing Therapeutic Bottlenecks & Advance Production

1:30 pm Guiding mRNA Format Selection with Analytical Strategies to Match Modality-Specific Needs in Gene Editing

Linnea Jansson-Fritzberg, Scientist II, Editas Medicine

2:00 pm Innovation in Assays and Enzymes of RNA Therapeutics Development

Dr. Qiuheng Jin, R&D Director, Vazyme

2:30 pm Synthetic Biology-Driven Innovation in mRNA Process Development

Diana M Posadas, Director - Strategic Research, GreenLight BioSciences

3:00 pm Session Reserved For Purilogics

Track 2: IND Enabling & Clinical Scale

3:10 pm Afternoon Break & Poster Presentations

Synopsis

Contribute to the conversation and share your cutting-edge research with like-minded mRNA experts. To present a poster, register your place and submit an abstract highlighting your breakthrough discovery. *Please visit the website for T&Cs for presenting a poster

Building Robust CMC Processes that Enable Scalable, Phase-Ready mRNA Development to Accelerate Clinical Advancement with Confidence

3:40 pm Defining CQAs, QC Methods & Release Specifications to Drive Consistency & Predictability in mRNA CMC Processing

4:10 pm Session Reserved For Aldevron

4:40 pm Streamlining Vaccine Release: Linking In Vitro Potency to In Vivo Immunogenicity for Smarter CMC Strategy

  • Gautam Sanyal Principal Consultant and Founder, Vaccine Analytics LLC.

5:10 pm End of Conference Day One